Do you want to read an article? Please log in or register.
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission
Gastrointestinal Diseases
Related content
Inflammatory Bowel Disease
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
Dig Dis Sci.
Iborra M, Herreras J, Boscá-Watts MM, Cortés X, Trejo G, Cerrillo E, Hervás D, Mínguez M, Beltrán B, Nos P
doi: 10.1007/s10620-018-5429-1.
Inflammatory Bowel Disease
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Lancet Gastroenterol Hepatol.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group
doi: 10.1016/S2468-1253(19)30012-3.
Inflammatory Bowel Disease
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy
J Crohns Colitis.
Messadeg L, Hordonneau C, Bouguen G, Goutorbe F, Reimund JM, Goutte M, Boucher AL, Scanzi J, Reymond M, Allimant C, Dapoigny M, Pereira B, Bommelaer G, Buisson A
doi: 10.1093/ecco-jcc/jjaa098.
RECOMMENDED
Inflammatory Bowel Disease
Risk of Late Post-Operative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
doi: 10.1016/j.cgh.2020.05.027.
Inflammatory Bowel Disease
Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial
Gastroenterology.
Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamali H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J
doi: 10.1053/j.gastro.2019.04.021.
Esophagus DiseasesInflammatory Bowel Disease
Diagnosis and outcome of oesophageal Crohn's disease
J Crohns Colitis.
Vale Rodrigues R, Sladek M, Katsanos K, van der Woude CJ, Wei J, Vavricka SR, Teich N, Ellul P, Savarino E, Chaparro M, Beaton D, Oliveira AM, Fragaki M, Shitrit AB, Ramos L, Karmiris K, ECCO CONFER investigators.
doi: 10.1093/ecco-jcc/jjz201.
Inflammatory Bowel Disease
High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS
doi: 10.1093/ibd/izy378.
Inflammatory Bowel Disease
Safety of hydrocortisone premedication discontinuation in patients with inflammatory bowel disease on maintenance therapy with Infliximab: a prospective clinical and pharmacological study
J Crohns Colitis
Tran-Minh ML, Gornet JM, Maillet M, Houze P, Simon M, McLellan P, Hassid D, Vivier-Chicoteau J, Baudry C, Hammoudi N, Allez M
doi: 10.1093/ecco-jcc/jjaa231
Inflammatory Bowel Disease
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease
Clin Gastroenterol Hepatol.
Bossuyt P, Dreesen E, Rimola J, Devuysere S, De Bruecker Y, Vanslembrouck R, Laurent V, Zappa M, Savoye-Collet C, Pariente B, Filippi J, Baert F, D'haens G, Laharie D, Peyrin-Biroulet L, Vermeire S, Tailorix study group.
doi: 10.1016/j.cgh.2020.04.052.